APA (7th ed.) Citation

M, P., M, F., A, T., E, L., E, B., O, E., . . . M, G. (2016). Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection. Arthritis care & research, 68(6), 738. https://doi.org/10.1002/acr.22786

Chicago Style (17th ed.) Citation

M, Padovan, et al. "Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection." Arthritis Care & Research 68, no. 6 (2016): 738. https://doi.org/10.1002/acr.22786.

MLA (9th ed.) Citation

M, Padovan, et al. "Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection." Arthritis Care & Research, vol. 68, no. 6, 2016, p. 738, https://doi.org/10.1002/acr.22786.